Moleac is a biopharmaceutical company based in Singapore.

We bring together the best of Asian and Western medicines: We identify promising medicine discovered in China and develop them into Western mainstream medicine. We take two to three years to develop and bring to market new medicine.

Our first drug Neuroaid is focused on brain stroke recovery and is derived from Traditional Chinese Medicine. With compelling existing efficacy data, established safety, it has already gained registration in 6 markets already and is available around the world a name patient program and an e commerce platform. Neuroaid10 a specific blend for US market is available locally as a dietary supplement to help support neurological functions.

Moleac has a portfolio of in-licensed promising medicines currently undergoing development and clinical trials, the next product is expected to hit market towards the end of 2008.

We focus our research and development resources in areas where patients' needs are greatest. We own a pipeline of medicines and device in various stages of development to address unmet medical needs and improve people's lives for which we drive development and registration. We seek partners to bring these products to market. We continue to evaluate additional opportunities.

Moleac is headquartered in Singapore. Its operations and research are located in Biopolis, a world-class purpose built complex for biomedical sciences research www.biopolis.com.sg